Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 9;37(6):109969.
doi: 10.1016/j.celrep.2021.109969.

MicroRNA-29 specifies age-related differences in the CD8+ T cell immune response

Affiliations
Free article

MicroRNA-29 specifies age-related differences in the CD8+ T cell immune response

Kristel J Yee Mon et al. Cell Rep. .
Free article

Abstract

MicroRNAs (miRNAs) have emerged as critical regulators of cell fate in the CD8+ T cell response to infection. Although there are several examples of miRNAs acting on effector CD8+ T cells after infection, it is unclear whether differential expression of one or more miRNAs in the naive state is consequential in altering their long-term trajectory. To answer this question, we examine the role of miR-29 in neonatal and adult CD8+ T cells, which express different amounts of miR-29 only prior to infection and adopt profoundly different fates after immune challenge. We find that manipulation of miR-29 expression in the naive state is sufficient for age-adjusting the phenotype and function of CD8+ T cells, including their regulatory landscapes and long-term differentiation trajectories after infection. Thus, miR-29 acts as a developmental switch by controlling the balance between a rapid effector response in neonates and the generation of long-lived memory in adults.

Keywords: CD8+ T cell; activation threshold; adaptive immunity; extracellular vesicle; gene regulation; immunological memory; miR-29; microRNA; naive; neonate.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Authors Minh T. N. Le, Andrew Grimson, Brian D. Rudd, Kristel Yee Mon and Luyen Tien Vu, are co-inventors of a patent application entitled ‘Delivery of nucleic acids into T cells’ (US 63/000,468). Minh T.N. Le is a cofounder and advisor of Carmine Therapeutics, a company that develops EV-based therapeutics.

Publication types

MeSH terms